This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore how volatility affects retirees in index funds and what tactics—like rebalancing and withdrawal rules—can help manage risk.
23,516 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
The SEC is exploring a proposal that could let U.S. public companies report semiannually instead of quarterly, prompt...
The Supreme Court looks poised to restrict late mail ballots, a move that could impact voter turnout and state electi...
Oil prices moved on fresh signals from Tehran that Iran could charge tolls for ships passing through the Strait of Ho...
A political clash at the Milan Cortina Games after Trump described a U.S. Olympian as a 'real Loser' has ignited a de...
As housing constraints persist, accessory dwelling units are moving from niche option to mainstream. This piece expla...
In Q4 2025, mortgage originations hit $524 billion as lenders tighten standards, yet the real story lies in who quali...
Legislation momentum revives the XRP ETF narrative as institutions eye regulated XRP exposure via XRPFi on Flare, wit...
Ford stock rallies on stronger-than-expected results, lifting full-year guidance. ford zooms higher, easily outpacing...
Bitcoin stands at a critical crossroads, pulled by a $177 leveraged ETF surge but tested by rising inflation and loom...
SpaceX is rumored to target a June 12 IPO, igniting widespread speculation about a valuation that could dwarf most te...
Arm Holdings has surged 104% year-to-date, with the AI pivot and AGI CPU driving demand. Smart money sits near a spec...